PFIZER INC — Director's Dealing 2020

Feb 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2020-02-26

Reporting Person: CANGIALOSI LORETTA V (Sr. Vice President, Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-26	Common Stock	M	24155.0000	$34.5900	Acquired	131196.0000	Direct
2020-02-26	Common Stock	A	3797.0000	$0.0000	Acquired	134993.0000	Direct
2020-02-26	Common Stock	F	1290.0000	$34.7200	Disposed	133703.0000	Direct
2020-02-26	Common Stock	F	1943.0000	$34.7200	Disposed	131760.0000	Direct
2020-02-26	Common Stock	F	18438.0000	$36.8000	Disposed	113322.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-26	Stock Appreciation Rights	$34.5900	M	24155.0000	Disposed	2020-02-26	Common Stock (24155.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2666.0000	Indirect

Footnotes

F1: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).

F2: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).

F3: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).

F4: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.

F5: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).

F6: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.